Background
==========

Diploid eukaryotic species inherit two copies (i.e., two alleles) of the same gene from both parents. If one allele fails to work properly, the other allele can still implement a gene's cellular function. For some genes, however, this protective mechanism is disabled because only one allele is expressed and its failure probably leads to cellular malfunction. These monoallelically expressed genes can be classified into one of three categories \[[@B1]\]: X-inactivated genes, which are regulated by a random process in which one of the two X chromosomes present in female mammals is silenced \[[@B2]\]; autosomal genes subject to random monoallelic gene expression, such as the T cell receptors and natural killer cell receptors \[[@B3]-[@B9]\]; and autosomal imprinted genes (e.g., *CDKN1C* and *H19*), which express from only one of the two alleles according to their parental origin \[[@B10]-[@B13]\]. Imprinted genes play important functional roles in the control of embryonic growth and development, as well as in post-natal development \[[@B14]-[@B16]\]. As imprinted genes are expressed from only one of the two parental chromosomes, a de facto haploid state is caused by imprinting and leads to asymmetric functions of parental genomes and loss of diploid protection against recessive mutations \[[@B11]\]. Thus, imprinting dysregulation is linked to numerous human genetic diseases, such as developmental disorders (Prader-Willi syndrome, Angelman syndrome) and cancers (neuroblastoma, Wilms' tumor) \[[@B17]-[@B20]\]. In addition, environmental factors can influence gene expression by targeting imprinted genes \[[@B21],[@B22]\]. Because imprinted genes are more susceptible to disease than non-imprinted genes \[[@B23],[@B24]\], it is of great importance to identify novel imprinted genes for human.

Identifying imprinted genes experimentally has traditionally been a slow process, and the number of validated ones is much lower than the previous estimation (\~1% of all human genes) \[[@B25]\]. However, recently developed high-throughput screening approaches (e.g., expression profiling and single-nucleotide polymorphism \[SNP\] microarrays) and recently identified DNA sequence characteristics (e.g., the number and type of repeated elements flanking a gene) have led to the proposal of several new methods to predict imprinted genes on a global scale \[[@B26]-[@B31]\]. With advances in next-generation sequencing technology \[[@B32],[@B33]\], mRNA-Seq is becoming a powerful tool for transcriptome profiling \[[@B34]\]. It can generate not only the number of reads mapped to exons, which reflects the expression levels of a gene, but also the actual sequence, which may identify the allele from which the mRNA is expressed. Therefore, inference can be made for predicting imprinted genes. For example, by sequencing whole transcriptomes from mice embryos, Babak *et al.* (2008) measured allelic expression bias and identified six novel imprinted genes \[[@B35]\].

However, to our knowledge, prediction of imprinted genes by deeply sequencing transcriptomes (mRNA-Seq) from multiple independent tissues is still an open problem. In this study, we proposed a Bayesian model -- dsPIG ([d]{.ul}eep [s]{.ul}equencing-based [P]{.ul}rediction of [I]{.ul}mprinted [G]{.ul}enes) -- to predict imprinted genes based on allelic expression inferred from observed SNPs in mRNA-Seq data of independent human tissues. With dsPIG, we were able to measure the imbalance of allelic expression among various tissues and calculate the posterior probability of imprinting status for each gene. Under a stringent probabilistic cut-off of the posteriors and other reasonable biological criteria, we identified 57 potentially imprinted genes from 9 diverse human tissues and 94 potentially imprinted genes from 20 cerebellar cortices, with an expected low false discovery rate (FDR). Furthermore, analysis of allelic expression of the same genes among different tissues revealed that, in some cases, even if a gene was biallelically expressed, one allele always had higher expression level than the other.

Results
=======

Statistical model development
-----------------------------

Monoallelic expression generally falls into one of three categories: imprinted expression, random monoallelic expression and X-inactivation, all of which express only one of two alleles in a single cell \[[@B1]-[@B10]\]. At a tissue level, however, random monoallelic expression will allow both alleles to be detected in total RNA because of the "mosaicism" of the tissue \[[@B9],[@B36]\] (also see discussion). Because our study was based on whole transcriptomes of tissue samples, random monoallelic expression was reasonably considered as biallelic expression when averaged over the entire tissue. X-inactivation was also excluded from this study by discarding all predictions on the X chromosome. Thus imprinting is the most likely cause of the observed monoallelic expression among transcriptomes of different tissues even though we cannot infer the parent of origin.

We used known SNPs from dbSNP \[[@B37]\] to distinguish and count the two alleles of each gene. If a gene was imprinted, we expected to observe only one of the two alleles of each SNP in the exon region from the whole transcriptome. With the allelic counts obtained from the mRNA-Seq data (see Materials and Methods), we developed a Bayesian model (dsPIG) to compute the posterior probability of imprinting based on each single SNP. Suppose we have sequenced transcriptomes from *n* independent tissue samples. For each sample, we count the alleles of all known SNPs, discarding those with 0 counts. For each SNP, let the allelic counts be: (*x*~*1*~*, y*~*1*~), (*x*~*2*~*, y*~*2*~)..., (*x*~*n*~*, y*~*n*~), where *x*~*k*~ and *y*~*k*~ are the counts for two alleles *X* and *Y* in the sample *k* (*k=*1*, ..., n*). Because each gene can only have two statuses: imprinted (*I*) or non-imprinted (*NI*), we consider (*I*, *NI*) as a binary event vector for the imprinting status. By denoting *data =* {(*x*~*1*~*, y*~*1*~), (*x*~*2*~*, y*~*2*~)..., (*x*~*n*~*, y*~*n*~)}, we have by Bayes' Theorem:

$$\Pr\left( I \middle| data \right) = \frac{\left( {\Pr data|I} \right) \times \Pr\left( I \right)}{\Pr\left( data \middle| I \right) \times \Pr\left( I \right) + \Pr\left( data \middle| NI \right) \times \Pr\left( {NI} \right)}$$

where Pr(*I* \| *data*) is the posterior probability of imprinting and Pr(*I*) is the prior of imprinting. Based on current knowledge of prevalence of imprinted genes \[[@B25]\], we set the prior Pr(*I*)=1%, thus Pr(*NI*) = 1 -- Pr(*I*) = 99%. Since samples were independent of each other and genotype has only 3 possible combinations (*XX, XY, YY*), we denote the genotype as follows:

$$\delta = \left\{ \begin{array}{l}
{1{\mspace{32mu}\text{the\ genotype\ is}\ }XX} \\
{2{\mspace{32mu}\text{the\ genotype\ is}\ }XY} \\
{{3\mspace{32mu}\text{the\ genotype\ is}\mspace{9mu}}YY} \\
\end{array} \right.$$

Assuming *p* and *q* are the allele frequencies for allele *X* and *Y*, *p* + *q* =1. According to Hardy-Weinberg equilibrium, the prior probabilities for the three genotypes are calculated as follows:

$$\Pr\left( \delta \right) = \left\{ \begin{array}{l}
{= \Pr\left( X \right)^{2} = p^{2}\mspace{86mu}\delta = 1} \\
{= \Pr\left( X \right)\Pr\left( Y \right) = 2pq\mspace{38mu}\delta = 2} \\
{= \Pr\left( Y \right)^{2} = q^{2}\mspace{85mu}\delta = 3} \\
\end{array} \right.$$

Since values of *p* and *q* can be retrieved from dbSNP \[[@B37]\], *p* and *q* are treated as constants.

We used the law of total probability to calculate the likelihood Pr(*data*\|*I*) as follows:

$$\Pr\left( {\text{data|}I} \right) = {\prod\limits_{k = 1}^{n}{\Pr\left( x_{k},y_{k} \middle| I \right)\mspace{108mu}\left( {n \geq 1} \right)}}$$

$$\begin{array}{l}
{= \prod\limits_{k = 1}^{n}\left\lbrack {\Pr,\left( x_{k},y_{k} \middle| I,\delta = 1 \right), \times ,p^{2}, + ,\Pr,\left( x_{k},y_{k} \middle| I,\delta = 2 \right)} \right)} \\
{\mspace{124mu}\left( {\times ,2,p,q, + ,\Pr,\left( x_{k},y_{k} \middle| I,\delta = 3 \right), \times ,q^{2}} \right\rbrack} \\
\end{array}$$

By assuming that (*i*) the transcript levels of a gene's two alleles are equal if the gene is biallelically expressed, (*ii*) two different alleles, if both expressed, have the same chance to be sequenced by mRNA-Seq, and (*iii*) unexpressed alleles with counts \>0 are due to sequencing errors, we had the following derivation:

$$\Pr\left( {x_{k},y_{k}|I,\delta = 1} \right) = f\left( {y_{k};n_{k},p_{e}} \right)$$

$$\Pr\left( {x_{k},y_{k}|I,\delta = 3} \right) = f\left( {x_{k};n_{k},p_{e}} \right)$$

$$\Pr\left( x_{k},y_{k} \middle| I,\delta = 2 \right)$$

$$\begin{array}{l}
{= \Pr\left( x_{k},y_{k} \middle| I,\delta = 2,\theta = 0 \right) \times \Pr\left( {\theta = 0} \right)} \\
{\mspace{68mu} + \text{Pr}\left( x_{k},y_{k} \middle| I,\delta = 2,\theta = 1 \right) \times \text{Pr}\left( {\theta = 1} \right)} \\
\end{array}$$

$$= f\left( {y_{k};n_{k},p_{e}} \right) \times \frac{1}{2} + f\left( {x_{k};n_{k},p_{e}} \right) \times \frac{1}{2}$$

Here, *f* denotes binomial distribution \[i.e., $f\left( {x;n,p} \right) = \left( \begin{array}{l}
n \\
x \\
\end{array} \right)\left( {1 - p} \right)^{({n - x})}p^{x}$\], *n*~*k*~ = *x*~*k*~ + *y*~*k*~ is assumed fixed, and *p*~*e*~ is the averaged sequencing error rate for each SNP (*p*~*e*~ was obtained from Wang *et al.* 2008). The binary variable θ is defined as follows $\theta = \left\{ \begin{array}{l}
{0{\quad\text{Only}\ }X{\ \text{can\ be\ expressed\ due\ to\ imprinting}}} \\
{1{\mspace{22mu}\text{Only}\mspace{9mu}}Y{\ \text{can\ be\ expressed\ due\ to\ imprinting}}} \\
\end{array} \right.$. Since *X* and *Y* have an equal chance to be inherited from either maternal or paternal genome, *X* and *Y* have an equal chance to be expressed in imprinted genes. Hence, $\Pr\left( \theta \right) = \left\{ \begin{array}{l}
{1/2\qquad\theta = 0} \\
{1/2\qquad\theta = 1} \\
\end{array} \right.$.

Similarly for the likelihood function Pr(*data*\|*NI*), we have:

$$\Pr\left( {data|NI} \right) = {\prod\limits_{k = 1}^{n}{\Pr\left( x_{k},y_{k} \middle| NI \right)\mspace{72mu}\left( {n \geq 1} \right)}}$$

$$\begin{array}{l}
{= \prod\limits_{k = 1}^{n}\left\lbrack {\Pr,\left( x_{k},y_{k} \middle| NI,\delta = 1 \right), \times ,p^{2}, + ,\Pr,\left( x_{k},y_{k} \middle| NI,\delta = 2 \right)} \right)} \\
{\mspace{153mu}\left( {\times ,2,p,q, + ,\Pr,\left( x_{k},y_{k} \middle| NI,\delta = 3 \right), \times ,q^{2}} \right\rbrack} \\
\end{array}$$

$$\Pr\left( {x_{k},y_{k}|NI,\delta = 1} \right) = f\left( {y_{k};n_{k},p_{e}} \right)$$

$$\Pr\left( {x_{k},y_{k}|NI,\delta = 3} \right) = f\left( {x_{k};n_{k},p_{e}} \right)$$

Based on our three assumptions (*i*) -- (*iii*), Pr(*x*~*k*~, *y*~*k*~\|*NI*, *δ* = 2) follows a binomial distribution with *p*=0.5. Therefore, we have:

$$\Pr\left( {x_{k},y_{k}|NI,\delta = 2} \right) = \left( \begin{array}{l}
{x_{k} + y_{k}} \\
{\quad x_{k}} \\
\end{array} \right)\left( \frac{1}{2} \right)^{x_{k} + y_{k}}$$

Computation is performed separately for each single SNP. Therefore, a posterior probability of imprinting for a gene is associated with a specific SNP in this gene, unless otherwise specified.

Simulation-based model analysis
-------------------------------

We generated allelic counts from simulated data by taking into account imprinting status, SNP frequency, and sequencing error. We then applied dsPIG to estimate the sensitivity, specificity and the FDR. We generated two sets of allelic counts under the assumption that the locus was either imprinted or not. The number of reads for each allele was generated assuming the presence of one dominating allele plus sequencing error for imprinted case; and presence of equal amount of two alleles plus sequencing error for non-imprinted case. The generated allelic counts followed a distribution similar to the actual mRNA-Seq data (Additional file [1](#S1){ref-type="supplementary-material"} Figure S1). More details of the procedure were illustrated in Additional file [2](#S2){ref-type="supplementary-material"} Figure S2. Given an allele frequency (0.5), a sequencing error (0.02) and a prior (0.01) of imprinting, the posterior probability calculated from the allelic counts generated for imprinted genes approached 1 as the sample size increased, while concomitantly the posterior probability for biallelically expressed approached 0 (Figure [1](#F1){ref-type="fig"}a,b; for each SNP, only the tissue samples with allelic counts \>2 were considered valid samples, and we used "sample size" to refer to the number of valid samples in this study). With minor allele frequencies between 0.005 to 0.5, sequencing errors between 0.01 to 0.05 and priors between 0.005 to 0.02, we obtained similar results as Figure [1](#F1){ref-type="fig"}a,b. Using 0.2 as the cut-off for posteriors Pr(*I* \| *data*) (see Model Analysis Based on Independent Test Sets), sensitivity of our model-based prediction exceeded 99.9% when sample size was \>9, and specificity exceeded 99.99% when sample size was \>18 (Figure [1](#F1){ref-type="fig"}c). Under the same cut-off and the allele frequency, the FDR of predicted imprinted genes decreased as sample size increased: it dropped to 5% and 1% as sample size exceeded 20 and 25, respectively (Figure [1](#F1){ref-type="fig"}d). Using the same cut-off (0.2), we also examined how FDR varied when minor allele frequency changed from 0.1 to 0.5 and sample size increased from 1 to 50 (Figure [2](#F2){ref-type="fig"}). Based on these simulations, we were able to provide estimated FDRs for most of our predictions in this study (Additional file [3](#S3){ref-type="supplementary-material"} Table S1).

![**Simulation-based performance analysis of dsPIG.a**, **b**, Simulated (natural log-transformed) posteriors of (**a**) biallelically expressed genes and (**b**) imprinted genes. The dashed line in both panels stands for the log-transformed prior (0.01). Results in (**a**) and (**b**) were based on 20,000-time simulations with geometric mean as the method of averaging posteriors. **c**, Sensitivity (the black solid line) and specificity (the read dashed line) of our model. **d**, the FDR of our predictions. When sample size was \<5, the FDR was not computable as sensitivity and specificity were both 0. Results in (**c**) and (**d**) were based on 20,000-time simulations with geometric mean as the method of averaging posteriors.](1471-2105-13-271-1){#F1}

![**FDRs of our predictions with respect to different allele frequencies.** When minor allele frequency (mAF) decreased from 0.5 to 0.1, FDR generally increased if sample size was \>10. Results were based on 20,000-time simulations. For detailed values of FDR, please refer to Additional file [4](#S4){ref-type="supplementary-material"}: Table S2.](1471-2105-13-271-2){#F2}

Predictions of imprinted genes
------------------------------

We collected two previously published mRNA-Seq data sets. One set included 9 diverse tissue samples (Group I) from Wang *et al.* 2008, and the other set had 20 cerebellum cortex samples (Group II) from Mudge *et al.* 2008 (Table [1](#T1){ref-type="table"}; see Data Collection in Materials and Methods) \[[@B38],[@B39]\]. Wang *et al.* 2008 showed that, in terms of alternative isoform expression, cerebellum tissues were clustered together and the 9 diverse samples were more closely correlated. Here we performed hierarchical clustering based on the imprinting-inclined SNPs (i.e., SNPs with posteriors \>0.01) and obtained similar results (Figure [3](#F3){ref-type="fig"}; see Sample Clustering in Materials and Methods). As we expected, samples from the cerebellar cortex were clustered together, with Caucasian and African American separated in two sub-clusters (Figure [3](#F3){ref-type="fig"}a). Using Caucasian allele frequency on African American samples, however, yielded a sub-cluster without separation between the two ethnicities (Figure [3](#F3){ref-type="fig"}b). This suggests that the separation observed in Figure [3](#F3){ref-type="fig"}a was due to differences in minor allele frequencies. As a test set, 3 breast cancer cell line samples were clustered together in both cases. Compared with other non-cerebellum samples, the brain sample had higher correlation with cerebellum samples in both cases, which is sensible biologically. The result that the 9 diverse tissue samples were clustered together could be caused by many factors such as different experimental conditions between Group I and Group II samples.

###### 

Sample information and sequencing results from 9 various normal tissues (Group I) and 14 cerebellar cortices with schizophrenia (SCZD) and 6 normal cerebellar cortices (Group II)

                **Sample**      **Type**    **Ethnicity**     **Average read length**   **Number of reads**   **Unique genomic reads**
  ---------- ----------------- ---------- ------------------ ------------------------- --------------------- --------------------------
  Group I         Adipose        Normal       Caucasian                 32                   27752231                   63%
                   Brain         Normal       Caucasian                 32                   17246957                   64%
                  Breast         Normal       Caucasian                 32                   16120746                   66%
                   Colon         Normal       Caucasian                 32                   28435996                   62%
                   Heart         Normal       Caucasian                 32                   20169301                   56%
                   Liver         Normal       Caucasian                 32                   18517121                   62%
                Lymph node       Normal       Caucasian                 32                   27492254                   57%
              Skeletal muscle    Normal       Caucasian                 32                   22640454                   64%
                  Testes         Normal       Caucasian                 32                   27303938                   68%
  Group II     Cerebellum 1       SCZD     African American             32                   23241938                   68%
              Cerebellum 11S      SCZD     African American             35                   14572861                   54%
               Cerebellum 18      SCZD        Caucasian                 32                   25129004                   69%
               Cerebellum 1S      SCZD        Caucasian                 32                   36760977                   64%
               Cerebellum 2       SCZD     African American             36                   19241726                   60%
               Cerebellum 31      SCZD        Caucasian                 36                   19867823                   63%
               Cerebellum 36      SCZD        Caucasian                 32                   20111871                   67%
               Cerebellum 39      SCZD     African American             33                   23055778                   63%
               Cerebellum 3S      SCZD     African American             34                   17846750                   46%
               Cerebellum 41      SCZD        Caucasian                 32                   38658913                   66%
               Cerebellum 42      SCZD     African American             35                   17588723                   56%
               Cerebellum 5       SCZD        Caucasian                 36                   21229299                   61%
               Cerebellum 5S      SCZD     African American             32                   28944566                   66%
               Cerebellum 7S      SCZD        Caucasian                 34                   13769073                   54%
               Cerebellum 17     Normal       Caucasian                 36                   12890252                   47%
               Cerebellum 2S     Normal       Caucasian                 36                   12482759                   44%
               Cerebellum 35     Normal    African American             36                   25402905                   63%
               Cerebellum 40     Normal       Caucasian                 36                   24486091                   64%
               Cerebellum 6S     Normal       Caucasian                 32                   24347196                   71%
               Cerebellum 8S     Normal    African American             32                   24016465                   71%

![**Sample clustering in terms of imprinting-inclined SNPs.** Spearman correlations were calculated between each pair of samples using the posterior on each SNP calculated by dsPIG in each sample. Hierarchical clustering was conducted with average linkage as the agglomerative method. Posterior probabilities of African American samples were computed with African American allele frequency in panel (**a**) and with Caucasian allele frequency in panel (**b**).](1471-2105-13-271-3){#F3}

Using dsPIG, we predicted imprinted genes for Group I and Group II separately. To call a gene imprinted, we checked the posteriors of all the SNPs on the same gene to make sure that (*i*) the gene had at least one SNP with a posterior \>0.2, which was the same cut-off used in simulations, and (*ii*) all the other SNPs did not show any contradictory evidence (i.e., all the other posteriors were \>0.002 \[our 20,000-time simulations showed that 95% of the posteriors of imprinted genes were \>0.002\]). After applying dsPIG to the mRNA-Seq data and using the above criteria, we predicted 57 potentially imprinted genes for Group I samples and 94 potentially imprinted genes for Group II samples out of a total of 20,559 genes (0.28% and 0.46%, respectively) that had allele frequency data in dbSNP. The distribution of sample sizes for SNPs was shown in Additional file [5](#S5){ref-type="supplementary-material"} Figure S3. We listed the top 15 predictions for both groups with respect to their posterior probabilities of imprinting in Table [2](#T2){ref-type="table"} (see Additional file [3](#S3){ref-type="supplementary-material"} Table S1 for the complete list). Surprisingly, we found only 13 common genes between the 57-gene list and the 94-gene list. Functional enrichment analysis performed in Ingenuity® Pathway Analysis (IPA) showed that the two lists of genes were significantly enriched (p-value\<0.05 after "BH" correction \[[@B40]\]) in certain Bio Functions but not in any canonical pathways defined by IPA (Additional file [6](#S6){ref-type="supplementary-material"} Figure S4). We also compared our predictions with the 371 genes that are subject to random monoallelic expression \[[@B1]\] and found none of our predicted genes in either group overlapped with them, which further validates the quality of our predictions and strongly suggests that our predictions are not affected by random monoallelic expression.

###### 

The top 30 predictions of imprinted genes based on mRNA-Seq data from Group I and Group II samples

  **SNP(rs\#)**    **Chr**   **Location**   **Str**   **Posterior**   **GeneID**    **Symbol**    **SS**   **FDR**   **Group**
  --------------- --------- -------------- --------- --------------- ------------ -------------- -------- --------- -----------
  11538691          chr17      4789783        \+            1            5216          PFN1         9         0          I
  178412            chr7       73173272       \-            1            3984         LIMK1         8         0          I
  17094371          chr14      57677831       \+            1           145407       C14orf37       9         0          I
  2596331           chr1      143820905       \-        0.999996         9554         SEC22B        7       0.26         I
  8110904           chr19      47723208       \+        0.999995         634         CEACAM1        4         0          I
  11555395          chr17      67629054       \+        0.999993         6662          SOX9         5         0          I
  4015375           chr7       89628110       \+         0.99997        26872         STEAP1        6         0          I
  4015375           chr7       89628110       \+         0.99997        256227       MGC87042       6         0          I
  10208923          chr2      141157767       \+         0.9998         53353         LRP1B         5         0          I
  9807047           chr17      46229893       \+        0.999751        731414      LOC731414       7         0          I
  584959            chr3       61703763       \+        0.995669      100128936      RPL10AP6       9       0.052        I
  10800864          chr1      201003241       \+        0.995398        10765         KDM5B         9       0.052        I
  10306             chr10      74437407       \-        0.993645         5033         P4HA1         4         0          I
  2009646           chr5      108148856       \+        0.989758         2241          FER          6         0          I
  2009646           chr5      108148856       \+        0.989758        643534      LOC643534       6         0          I
  178412            chr7       73173272       \-            1            3984         LIMK1         11      0.098       II
  11538691          chr17      4789783        \+            1            5216          PFN1         20      0.023       II
  11541557          chr1      226352225       \+            1            375           ARF1         9         0         II
  17492855          chr2      158989711       \+        0.999999        130940       CCDC148        18      0.014       II
  2352731           chr3      144378737       \+        0.999995         5089          PBX2         10      0.072       II
  1065453           chr7       99755171       \-        0.999992        441272        SPDYE3        5         0         II
  11066116          chr12     110915447       \+        0.999989        89894        TMEM116        8         0         II
  2499              chr6       30021520       \-        0.999982         3105         HLA-A         7       0.26        II
  3093976           chr6       31610839       \-         0.99993         7919          BAT1         8       0.12        II
  705               chr15      22770604       \+        0.999919         6638         SNRPN         20      0.023       II
  705               chr15      22770604       \+        0.999919         8926         SNURF         20      0.023       II
  3132453           chr6       31712022       \-        0.999913         7916          BAT2         4         0         II
  1051470           chr12     117067614       \+        0.999874         5037         PEBP1         14      0.051       II
  1364261           chr16      70597171       \-        0.999859      100130263    LOC100130263     8         0         II
  11160608          chr14     100382845       \+        0.999796      100130955    LOC100130955     20      0.023       II

Abbreviations: rs\#-SNP identification number, Chr-chromosome, Str-strand, SS-sample size.

Model analysis based on independent test sets
---------------------------------------------

We collected 66 validated imprinted genes and 155 validated non-imprinted genes (\[[@B31],[@B41]\]; see Data Collection) and used them to check for false-positive and false-negative predictions made by dsPIG. Based on the mRNA-Seq data of Group I samples, 28 of the 66 imprinted genes and 119 of the 155 non-imprinted genes had allelic counts for known SNPs; based on the mRNA-Seq data of Group II samples, 26 of the 66 imprinted genes and 110 of the 155 non-imprinted genes had allelic counts for known SNPs. Under the same criteria used to predict imprinted genes in Table [2](#T2){ref-type="table"}, dsPIG identified 2 out of 28 imprinted genes from Group I samples and 9 out of 26 imprinted genes from Group II samples, based on the mRNA-Seq data; under the same criteria, dsPIG misidentified 0 out of 119 non-imprinted genes from Group I samples and 0 out of 110 non-imprinted genes from Group II samples. Moreover, among those imprinted genes, only 8 out of 28 (Group I) and 17 out of 26 (Group II) have sample sizes \>5. On the contrary, all 11 dsPIG-identified imprinted genes (2 for Group I and 9 for Group II) have sample size \>5. Therefore, for imprinted genes with sample size \> 5, 2 out of 8 genes and 9 out of 17 genes could be identified by dsPIG for Group I and Group II, respectively. Again, this showed that the sensitivity of dsPIG increased as sample size increased and dsPIG could probably identify more imprinted genes if the number of sequenced tissue samples further increased. This also agreed with the simulation results. Interestingly, some of the validated imprinted genes had very small posteriors (\<10^-8^), which indicated that they had biallelic expression (or random monoallelic expression) in certain tissues (Table [3](#T3){ref-type="table"}).

###### 

Tissues where validated imprinted genes most likely had biallelic expression

  **SNP(rs\#)**    **Chr**   **Location**   **Str**   **Posterior**   **Gene ID**   **Gene Symbol**     **Tissue**      **Group**
  --------------- --------- -------------- --------- --------------- ------------- ----------------- ----------------- -----------
  3807551           chr7       50627897       \-        6.84E-17         2887            GRB10        Skeletal Muscle       I
  2585              chr11      2107019        \+        9.09E-210        3481            IGF2              Liver            I
  10770125          chr11      2125589        \+        7.15E-43         3481            IGF2              Liver            I
  8813              chr11      3065081        \-        1.20E-11        114879          OSBPL5             Colon            I
  17178177          chr11      3065446        \+        6.83E-10        114879          OSBPL5             Colon            I
  10770125          chr11      2125589        \+        7.15E-43         51214          IGF2AS             Liver            I
  7121              chr20      56912201       \+            0            2778            GNAS           Lymph node          I
  854547            chr7       94761791       \+        1.61E-10         55607          PPP1R9A         Cerebellum         II
  8164              chr11      6372457        \+        1.54E-30         6609            SMPD1          Cerebellum         II
  7951904           chr11      6369506        \+        2.68E-10         6609            SMPD1          Cerebellum         II
  11601088          chr11      6371967        \+        1.62E-09         6609            SMPD1          Cerebellum         II
  2272666           chr8       1.46E+08       \+        2.63E-17         79581          GPR172A         Cerebellum         II
  2280840           chr8       1.46E+08       \+        1.05E-57         79581          GPR172A         Cerebellum         II
  2615374           chr8       1.41E+08       \+        1.51E-13         51305           KCNK9          Cerebellum         II

Posteriors were calculated based on Group I or II (see Table [5](#T5){ref-type="table"}). The "Tissue" column indicates where genes were most likely biallelically expressed. Genes with contradictory evidence (i.e., genes had posteriors \<10^-8^ and posteriors ≥0.2) were discarded. IGF2, OSBPL5, SMPD1 and GPR172A had at least 2 SNPs with posteriors less than 10^-8^. Abbreviations are the same as in Table [2](#T2){ref-type="table"}.

We used the same sets of imprinted and non-imprinted genes to determine the cut-off of the posteriors used in the prediction of imprinted genes. Because most genes (\~99%) are expected to be non-imprinted, the cut-off has to yield a very high specificity (\>99%) so that the overall FDR of our predictions can be low enough (\<50%) for further validations. After trying different cut-offs (0.1, 0.2, ..., 0.9), we found 0.2 to be the most appropriate cut-off in terms of the validated gene sets because (*i*) increasing the cut-off from 0.2 only lowered the sensitivity while left the specificity unchanged (\~0%), and (ii) decreasing the cut-off from 0.2 lowered the specificity while the sensitivity didn't change a lot, which substantially increased the FDR of predictions (Additional file [7](#S7){ref-type="supplementary-material"}: Figure S5). We also showed the ROC curves for dsPIG in Additional file [7](#S7){ref-type="supplementary-material"}: Figure S5.

Candidates for experimental validation
--------------------------------------

We chose top 30 candidate genes from our predictions and listed them in Table [4](#T4){ref-type="table"}. Except one SNP (rs\#3106189), all the SNPs in Table [4](#T4){ref-type="table"} have high minor allele frequencies (\>0.184), which indicates \>30% chance of observing heterozygous alleles in experiments. In addition, these genes also met at least one of the following three criteria: (*i*) their SNPs (the 4^th^ column of Table [4](#T4){ref-type="table"}) had a relatively low FDR (\<0.3), (*ii*) they had multiple SNPs with posteriors \> 0.2 (dsPIG calculated a posterior for each SNP in a gene), and (*iii*) they were located near existing imprinted genes (distance \<2M base pairs) \[[@B10],[@B42]\]. These additional criteria further increased the possibility of imprinting.

###### 

Suggested predictions for experimental validation.

  **Gene Symbol**     **Chr**   **Str**   **SNP(rs\#)**   **Location**   **Posterior**   **SS**   **FDR**   **Group**
  ------------------ --------- --------- --------------- -------------- --------------- -------- --------- -----------
  CCDC148              chr2       \+        17492855       158989711      0.999999314      18      0.014       II
  [BAT1]{.ul}          chr6       \-         3093976        31610839      0.999930191      8       0.12        II
  PEBP1                chr12      \+         1051470       117067614      0.999873859      14      0.051       II
  **LOC100130955**     chr14      \+        11160608       100382845      0.999795515      20      0.023       II
  RPL10AP6             chr3       \+         584959         61703763      0.999517203      11      0.055       II
  KCNJ12               chr17      \+        16962951        21259999      0.998953843      11      0.055       II
  VARS2                chr6       \+         1043483        31001706      0.998607936      14      0.051       II
  [BAT2]{.ul}          chr6       \-         2272593        31709322      0.998223631      9       0.052       II
  RPL10AP6             chr3       \+         584959         61703763      0.995668725      9       0.052        I
  KDM5B                chr1       \+        10800864       201003241      0.995398014      9       0.052        I
  [TAPBP]{.ul}         chr6       \-         1059288        33375649      0.995270134      13      0.057       II
  KCNQ5                chr6       \-         2000203        73753786      0.993101795      13      0.069       II
  FER                  chr5       \+         2009646       108148856      0.989758091      6         0          I
  LOC643534            chr5       \+         2009646       108148856      0.989758091      6         0          I
  LY6G5B               chr6       \-         1266076        31748496      0.98719144       16      0.028       II
  NOMO2                chr16      \+          7179          14897344      0.979473344      7         0         II
  BAT5                 chr6       \-         1475865        31765391      0.979015507      7         0         II
  RXRB                 chr6       \-          6531          33271428      0.977747582      6         0         II
  FER                  chr5       \+         2009646       108148856      0.962143895      6         0         II
  [ZBTB22]{.ul}        Chr6       \-         1061783        33390605      0.96804794       12      0.076       II
  LOC283398            chr12      \-         3827521        93467186      0.908227908      7         0          I
  UCRC                 chr22      \+          14115         28493525      0.889141351      15      0.039       II
  MT2A                 chr16      \+          10636         55200843      0.709333922      10      0.142       II
  RQCD1                chr2       \+         526897        219141840      0.683651187      13      0.128       II
  PSMC3IP              chr17      \-          6963          37985122      0.661403579      12      0.146       II
  **CSTF3**            chr11      \-         1028564        33118584      0.479199531      8       0.373       II
  **LOC100128252**     chr19      \+         3971706        61697880      0.478128233      4       0.343        I
  **LOC100130814**     chr14      \-         2295655       100608883      0.446498085      18      0.228       II
  **IMPDH1**           chr7       \-         2228075       127821864      0.283348511      17      0.318       II
  [CLDN4]{.ul}         chr7       \+         1127155        72884396      0.270700082      4       0.594        I

Boldface indicates proximity to known imprinted genes. Underline indicates a gene has multiple (≥3) SNPs with posteriors \> 0.2. Genes are sorted by their posteriors. RPL10AP6 and FER are listed for both Group I and Group II. Abbreviations are the same as in Table [2](#T2){ref-type="table"}.

Detection of allele-preferred expression
----------------------------------------

By investigating the biallelically expressed genes identified in the mRNA-Seq data, we found that at least 18 genes expressed significantly more transcripts from one specific allele than the other among various individuals and tissues (*P* \< 0.05 by binomial test; Table [5](#T5){ref-type="table"}; see Binomial Test in Materials and Methods). This indicated that the difference between expression levels of the two alleles was not caused by sequencing errors or stochastic effects in RT-PCR. In future, as more mRNA-Seq data are generated, if more genes with one specific allele always under-expressed are observed, we would speculate that a sophisticated mechanism (such as nonsense-mediated mRNA decay \[[@B43]\]) may exist to explain this type of allelic preference in gene expression for biallelically expressed genes.

###### 

20 SNPs of which one specific allele had a higher transcript level than the other one among various tissues and individuals

  **SNP**       **Chr**   **Position**   **Str**   **Ratio**   **P-value**    **Gene Symbol**
  ------------ --------- -------------- --------- ----------- ------------- --------------------
  rs13884        chr19      18545100       \+        1/24       3.58E-05           UBA52
  rs4621         chr11      65380094       \+        0/17       9.16E-05            CFL1
  rs425485       chr19      3004801        \+        0/13      0.000976563          AES
  rs4874         chr17      17227958       \-        0/12      0.001171875       LOC388344
  rs6565924      chr18      72820212       \+        0/12      0.001171875          MBP
  rs6554         chr19      18546963       \+        0/11      0.001953125         UBA52
  rs11543289     chr17      34136120       \+        0/10      0.003348214   MLLT6/LOC100129395
  rs17626        chr19      44618360       \-        1/13      0.005126953         RPS16
  rs8118         chr16      4787169        \-         0/9      0.005208333         ROGDI
  rs9199         chr18      72821323       \-         0/8       0.009375            MBP
  rs7612         chr7       5533637        \+        1/11      0.01171875           ACTB
  rs6597982      chr11       778006        \-        1/11      0.01171875          CEND1
  rs1803283      chr14      1.03E+08       \-        2/14      0.011944111          CKB
  rs7982         chr8       27518397       \-        2/13      0.015854779          CLU
  rs3743566      chr16      57103285       \+        2/13      0.015854779         NDRG4
  rs2821         chr20      5853778        \+        3/16      0.015854779          CHGB
  rs7121         chr20      56912201       \+        3/16      0.015854779          GNAS
  rs12165042     chr17      30502328       \+        4/18      0.020589193         UNC45B
  rs1150         chr17      8003307        \+        2/12      0.024362664         VAMP2
  rs10064485     chr5       1.75E+08       \+        2/11      0.039257813         CPLX2

The "Ratio" column shows the proportion of samples with one specific allele's transcript level higher than the other's. P-values have been adjusted by "BH" correction \[[@B40]\]. Abbreviations are the same as in Table [2](#T2){ref-type="table"}.

Web-based service and R package for dsPIG
-----------------------------------------

We have provided a web-based service for dsPIG at <http://www.shoudanliang.com/dsPIG/>. Users need to upload either mapped mRNA-Seq data in the supported format or processed data files containing allelic counts for each SNP (see the website for more details). After uploading the data, users may set the values for (*i*) the cut-off for posteriors, (*ii*) the average sequencing error rate, (*iii*) the prior of imprinting, and (*iv*) QS (quality score). In addition, users need to specify the human genome build and the SNP build for dsPIG. Our server will calculate the posterior probabilities of imprinting for each gene and email the results back to the users. In the final submission form, users may request additional analysis, such as suggesting tissues where known imprinted genes most likely have biallelic expression. In addition, we have made an R package for dsPIG, which is available both on the website and in the supplementary materials (Additional file [8](#S8){ref-type="supplementary-material"} for UNIX and Additional file [9](#S9){ref-type="supplementary-material"} for Windows). The instruction and the sample files for this R package are in Additional file [10](#S10){ref-type="supplementary-material"}. The web service and the R package generate the same result on the predictions of imprinted genes. For reference, we have also provided the annotated code for dsPIG (including both the R code and the C code) used in this study as Additional file [11](#S11){ref-type="supplementary-material"} and on the website.

Discussion
==========

dsPIG operates under the assumption that if a gene is biallelically expressed, the transcript levels of two alleles are the same. However, because imbalance of allelic expression has been widely detected in human tissues \[[@B27],[@B44]-[@B46]\], our assumption may not always be correct. Indeed, within our 29-tissue samples, allelic imbalance was observed even after excluding possible expression from imprinted genes (data not shown here). However, our simulation studies showed that our model can still distinguish imprinted genes from non-imprinted ones in most situations (Figure [4](#F4){ref-type="fig"}), unless one specific allele is always expressed at \<13% of the other allele's expression level across different samples (no supporting literature for this yet). Stochastic RT-PCR amplification \[[@B4]\] is not of particular concern in dsPIG because this has been taken into account as allelic imbalances.

![**Effect of imbalanced transcript levels on the posteriors of biallelically expressed genes.** Solid lines stand for simulated posteriors for imprinted genes (black line) and biallelically expressed genes (non-black lines). "Randomly imbalanced" means that in each sample we randomly picked one allele to have a lower expression level than the other allele. FIC indicates "Fixed Imbalanced Coefficient", which means one allele is always expressed at a "FIC" level of the other one in all samples. The dashed line stands for the log-transformed prior. When FIC is low enough (typically \<13%), posteriors are not able to tell the difference between imprinted (solid black line) and biallelic expression (green line).](1471-2105-13-271-4){#F4}

dsPIG is sensitive to biallelic expression and unlikely to falsely predict imprinted genes. A gene will get a very low posterior probability of imprinting when it obviously has biallelic expression in one tissue, even if only one allele of this gene is observed in the transcriptomes from all other tissues (Additional file [12](#S12){ref-type="supplementary-material"}: Figure S6). For example, a gene may have monoallelic expression because of allele-specific differences caused by either heterozygous SNPs or somatic mutations in the promoter region of the gene; as long as monoallelic expression caused by these conditions is not present population-wide and a large number (e.g., \>25 in our study) of independent tissue samples is used in dsPIG, these genes will not be falsely predicted as imprinted genes. However, for the same reason, if transcriptomes are collected from various tissues, it becomes very hard for dsPIG to detect tissue-specific imprinted genes. This partially explains why dsPIG predicted much less imprinted genes in Group I samples than in Group II samples (another reason is that Group II has more samples than Group I).

One advantage of dsPIG is that it is able to predict imprinted genes without sequencing the genotype. Although a homozygous allele will also lead to identification of only one allele in the transcriptome, the result will not elevate the posterior belief of imprinting in our model. This is very important and practical for human because we no longer need to sequence the genome for genotypes. However, a disadvantage is that dsPIG cannot tell the parent of origin for predicted imprinted genes, which can be verified only by other studies.

One obvious limit of dsPIG is that it was modeled based on single SNPs. This means, if a gene has more than 1 SNP site in its exons, it may have different single-SNP-based allelic counts and thus different posterior probabilities from dsPIG. Therefore, one single strong posterior cannot determine the imprinting status of this gene. Instead, we have to look into all SNP sites of each gene and make sure no contradictory posterior exists for our predictions (as stated in results). In future, a possible improvement would be integration of all SNP information of a gene and calculate a single posterior to predict imprinting status.

Conclusions
===========

In this paper, we proposed a new method -- dsPIG, applicable to all mammals with genomic imprinting, to predict imprinted genes based on mRNA-Seq data of various independent tissues. With enough sequenced samples, dsPIG is capable of predicting imprinted genes on a genome-wide scale with expected low FDRs. The power of dsPIG will be further enhanced after more data generated by mRNA-Seq technology become available in the near future.

Methods
=======

Data collection
---------------

To predict gene imprinting status, we used \~650 million short reads from 29 human tissue samples \[[@B38],[@B39]\]: 206 million from 9 different normal tissues, 320 million from 14 cerebellar cortices with schizophrenia and 124 million from 6 normal cerebellar cortices. Tissue samples were collected from 29 independent individuals, among which 20 were Caucasian and 9 were African American (Table [1](#T1){ref-type="table"}). We downloaded SNP data from UCSC genome browser using the table function \[[@B47]\] and used SNPs with only two alleles to make predictions in this study. The source of the original data was SNP Database (dbSNP) build 129 from NCBI \[[@B37]\]. Known imprinted and non-imprinted genes were collected from Additional file [3](#S3){ref-type="supplementary-material"}: Table S1 and Additional file [4](#S4){ref-type="supplementary-material"}: Table S2 in the supplementary research data of Luedi *et al.* (2007) \[[@B31]\] and from Catalogue of Parent of Origin Effects (<http://igc.otago.ac.nz/home.html>) \[[@B41]\].

Calculation of allelic counts
-----------------------------

RNA-Seq reads were mapped to human genome hg18 from UCSC genome browser using Eland (GAPipeline-1.3.2). The unmapped reads were mapped to the exon-exon junctions downloaded from <http://genes.mit.edu/burgelab/mrna-seq/>\[[@B38]\]. The junctions contain 56 (28×2) base pairs in total, allowing the reads (32 base pairs) to be mapped with a minimum of 4 base pairs on each side of the junctions \[[@B38]\]. To compute the number of alleles for each SNP, we scanned each mapped tag for all known SNPs (in terms of dbSNP) and counted the number of times each nucleotide occurred at each SNP position in each sample. To reduce the amount of calculation, we only retained SNPs that were covered by any sequencing tag in any sample. This generated allelic counts for a total of 1,261,906 SNPs in the 29 tissue samples. We then discarded SNPs with unknown frequency and very low allelic counts (i.e., total allelic counts \<3 in each sample). In addition, we defined a quality score-QS (see Definition of QS) and discarded SNPs with QS \<0.9 in all 29 samples (see Additional file [13](#S13){ref-type="supplementary-material"}: Figure S7). After these steps, allelic counts for 82,916 SNPs remained, and these were used in dsPIG.

Definition of QS
----------------

We only used biallelic SNPs in dbSNP, which is the majority of SNPs. Nucleotides observed other than these two (alleles) were considered as sequencing errors due to low sequencing quality at the SNP site, or indicted that the allelic information of the SNP was wrong in dbSNP. Thus, we defined quality score-QS to improve the quality of the SNPs used in our predictions:

$$\text{QS}_{k} = \frac{x_{k} + y_{k}}{x_{k} + y_{k} + e_{k}}$$

In the above equation, *x*~*k*~ and *y*~*k*~ are the allelic counts of allele *X* and *Y* in the kth sample (*X* and *Y* were determined by dsSNP), and *e*~*k*~ is the count of additional nucleotide(s). QS was calculated for each SNP in each sample. We arbitrarily chose 0.9 as a cut-off for QS ( [Additional file 13](#S13){ref-type="supplementary-material"}: Figure S7) and only those SNPs with QS\>0.9 were used in dsPIG.

Sample clustering
-----------------

By applying dsPIG to each of the 29 samples, we obtained 29 lists of posterior probabilities (each list had 87,852 posteriors for 87,852 SNPs), which were first multiplied by 100 and then natural logarithm transformed. Thus, if the posterior was the same as the prior (0.01), it would become 0 after the transform. After that, for each SNP, all posteriors ≤ 0 were modified to 0, while all posteriors \> 0 were kept at the same value. If all 29 posteriors for a SNP were 0, the SNP was removed from the 29 lists. By doing this, only the SNPs that showed an increased probability of imprinting were kept for clustering. We then computed spearman correlations between samples based on the remaining 29 lists of posteriors, used these correlation values to determine distance between samples, and performed hierarchical clustering in R (<http://www.r-project.org>). By using this method, we clustered samples in terms of imprinting-inclined SNPs, and thus reduced the influence of biallelically expressed genes.

Binomial test
-------------

For a single SNP, we first defined $P_{k} = \frac{x_{k}}{y_{k}}$, where *x*~*k*~ and *y*~*k*~ are the allelic counts for its alleles *X* and *Y* in the sample *k* (*k=1, ..., n*). We then defined $z = {\sum\limits_{k = 1}^{n}{I\left( P_{k} \right)}}$, where $I\left( P_{k} \right) = \left\{ \begin{array}{l}
{1,{\ \text{if}\ }P_{k} > 1} \\
{0,{\ \text{if}\ }P_{k} < 1} \\
\end{array} \right.$. We used the following criteria to find the SNPs with both alleles (*XY*) expressed in the sample *k*: *x*~*k*~\>10, *y*~*k*~\>10, *x*~*k*~+*y*~*k*~\>50, *x*~*k*~/*y*~*k*~\<10 and *y*~*k*~/*x*~*k*~\<10. The criteria made it very unlikely to observe biallelic expression because of sequencing error. For each SNP that met the criteria in *n* samples, if no allele was preferably expressed by the transcription machinery, *z* should follow a binomial distribution *f*(*z*; *n*, *p*) with *p*=0.5. To obtain enough testing power, SNPs with *n* ≥ 8 were deemed qualified for the binomial test. Under the above criteria, we found 24 qualified SNPs and listed all 20 significant testing results in Table [5](#T5){ref-type="table"}.
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###### Additional file 1

**Figure S1.** Distribution of simulation-generated allelic counts vs. observed distribution in real data. Red line stands for the generated distribution; black line stands for the observed distribution. The red text and black text in the upper right green box are summarized statistics for red line and black line, respectively
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###### Additional file 2

**Figure S2.** Flowchart showing steps in data simulation and model assessment. In step 2, the differences in data generation are caused by two factors: (*i*) imprinted genes need to express only one allele at a tissue level while non-imprinted genes don't, (*ii*) two alleles expressed from non-imprinted genes need to be sequenced in RNA-Seq with an equal probability, while imprinted genes only have one allele expressed. In this step we also need to assume that sequencing error leads to misread of one nucleotide to the other three with an equal probability. RT-PCR amplification is not shown in the process because we assume that it amplifies both alleles synchronously (for details, see Discussion)
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###### Additional file 3

**Table S1.** The predicted imprinted genes based on mRNA-Seq data from Group I and Group II samples. Abbreviations: rs\#-SNP identification number, Chr-chromosome, Str-strand, SS-sample size. "NA" in the "FDR" column means the FDR could not be estimated based on our 20,000-time simulations
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###### Additional file 4

**Table S2.**The FDR values with respect to different sample sizes and allele frequencies. " NA" means FDR could not be estimated based on our 20,000-time simulations
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###### Additional file 5

**Figure S3.** Distribution of SNPs' sample sizes in Group I (from 9 diverse tissue samples) and Group II (from 20 cerebellum samples). Group I and Group II had a total of 44007 SNPs and 66294 SNPs with sample size \>0, respectively
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###### Additional file 6

**Figure S4.** Functional enrichment analysis of the 57 genes and the 94 genes in Ingenuity® Pathway Analysis. (*a*) Comparison of enrichment in Bio Functions between the two gene lists. (*b*) Comparison of enrichment in Canonical Pathways between the two gene lists. The height of each bar in (*a*) and (*b*) represents the logartihm (10-based) transformed p-values calculated from Fisher's exact test. In (*a*), the horizontal yellow line is the threshold \[i.e., -log~10~(0.05)\] above which bars (p-values) were considered significant; in (*b*), there is no bar above the threshold which is not shown here. (Figure S4 is located in a separate PDF file: "Fig. S4.pdf".)
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###### Additional file 7

**Figure S5.** Sensitivity and specificity analysis of dsPIG based on the genes with known patterns of allelic expression. (*a*) Sensitivity analysis based on the validated imprinted genes. (*b*) Specificity analysis based on the validated non-imprinted genes. In (*a*) and (*b*), the solid black lines, which showed the numbers of genes identified by dsPIG as "imprinted", were based on the mRNA-Seq data of Group I samples, and the dotted black lines were based on Group II samples; the red line is the cut-off (0.2) used in this study to predict imprinted genes. (*c*) ROC curve for dsPIG based on Group I samples. (*d*) ROC curve for dsPIG based on Group II samples
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###### Additional file 8

R package (dsPIG, version 3.0) for UNIX).
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###### Additional file 9

R package (dsPIG, version 3.0) for Windows).
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###### Additional file 10

The instruction and the sample files for the R package of dsPIG.
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###### Additional file 11

The annotated R code and C code for dsPIG used in our study.
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###### Additional file 12

**Figure S6.** Simulated (log-transformed) posteriors of genes with biallelic expression in only one sample. Each positive integer (*x*) on the *x*-axis ("Sample size") includes two parts: 1 sample of biallelic expression and (*x*-1) samples of imprinted expression. Posteriors were calculated by dsPIG. The dashed line stands for the log-transformed prior (0.01). This result was based on 20,000-time simulations with geometric mean as the method of averaging posteriors
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###### Additional file 13

**Figure S7.** Distributions of QS in 32 samples (including 3 breast cancer cell line samples). The *x*-axis is the number of sequencing tags that covered the SNP site, and the *y*-axis is the QS. Tissue names are located at the lower right side of each plot, where "Cancer" stands for "breast cancer cell line sample" and "C." stands for "cerebellum sample". Dashed lines in the 32 samples represent the cut-off (0.9) for QS
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